Arkansas Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center

• Category: Corporations - Public - Licenses
• State: Multi-State
• Control #: US-EG-9161
• Format: Word; Rich Text

Description

Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center at Forth Worth dated July 1, 1996. 2 pages The Arkansas Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a binding contract that outlines the terms and conditions related to the licensing of collateral materials and intellectual property. This agreement serves to protect the interests of both parties involved, ensuring that Gentling retains the right to use certain collateral materials while granting The University of North Texas Health Science Center limited usage rights. The agreement aims to facilitate collaborative research and development initiatives between the two entities, promoting the advancement of scientific knowledge and the commercialization of relevant discoveries. Within this agreement, there may be different types or provisions that address specific aspects of collateral licensing. These may include: 1. Exclusive Collateral License Agreement: This type of arrangement would grant Gentling exclusive rights to use the collateral materials, restricting The University of North Texas Health Science Center from providing similar licenses to any other party. 2. Non-Exclusive Collateral License Agreement: In this case, both Gentling and The University of North Texas Health Science Center have the freedom to grant collateral licenses to other parties outside the agreement. This allows for wider dissemination of the intellectual property while still maintaining a beneficial partnership. 3. Term-Limited Collateral License Agreement: This type of agreement specifies a predetermined period during which Gentling has the right to use the collateral materials. Once the agreed-upon time frame elapses, the license becomes void unless renewed by mutual consent. 4. Royalty-Based Collateral License Agreement: This provision outlines the payment of royalties by Gentling to The University of North Texas Health Science Center, usually a percentage of the revenue generated from the use of licensed collateral materials. This allows for a mutually beneficial financial arrangement for both parties. Key terms and elements commonly found in the Arkansas Collateral License Agreement may include clauses addressing confidentiality, assignment and sublicensing rights, dispute resolutions, termination conditions, and ownership of improvements or modifications made to the collateral materials. Overall, this detailed description highlights the importance of the Arkansas Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center in safeguarding the rights and interests of both parties, while facilitating collaborative research, development, and commercialization efforts. These collaborations have the potential to accelerate scientific advancements, benefit society, and contribute to the growth of both organizations involved.

The Arkansas Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a binding contract that outlines the terms and conditions related to the licensing of collateral materials and intellectual property. This agreement serves to protect the interests of both parties involved, ensuring that Gentling retains the right to use certain collateral materials while granting The University of North Texas Health Science Center limited usage rights. The agreement aims to facilitate collaborative research and development initiatives between the two entities, promoting the advancement of scientific knowledge and the commercialization of relevant discoveries. Within this agreement, there may be different types or provisions that address specific aspects of collateral licensing. These may include: 1. Exclusive Collateral License Agreement: This type of arrangement would grant Gentling exclusive rights to use the collateral materials, restricting The University of North Texas Health Science Center from providing similar licenses to any other party. 2. Non-Exclusive Collateral License Agreement: In this case, both Gentling and The University of North Texas Health Science Center have the freedom to grant collateral licenses to other parties outside the agreement. This allows for wider dissemination of the intellectual property while still maintaining a beneficial partnership. 3. Term-Limited Collateral License Agreement: This type of agreement specifies a predetermined period during which Gentling has the right to use the collateral materials. Once the agreed-upon time frame elapses, the license becomes void unless renewed by mutual consent. 4. Royalty-Based Collateral License Agreement: This provision outlines the payment of royalties by Gentling to The University of North Texas Health Science Center, usually a percentage of the revenue generated from the use of licensed collateral materials. This allows for a mutually beneficial financial arrangement for both parties. Key terms and elements commonly found in the Arkansas Collateral License Agreement may include clauses addressing confidentiality, assignment and sublicensing rights, dispute resolutions, termination conditions, and ownership of improvements or modifications made to the collateral materials. Overall, this detailed description highlights the importance of the Arkansas Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center in safeguarding the rights and interests of both parties, while facilitating collaborative research, development, and commercialization efforts. These collaborations have the potential to accelerate scientific advancements, benefit society, and contribute to the growth of both organizations involved.